Microsalt PLC

Report Publication Announcement • Jun 2, 2025

National Storage Mechanism | Additional information

RNS Number : 9037K

MicroSalt PLC

02 June 2025

2 June 2025

MicroSalt plc

("MicroSalt" or the "Company")

Notice of Investor Presentation via Investor Meet Company

MicroSalt plc, (AIM: SALT), a leading manufacturer of full flavour salt with approximately 50% less sodium is pleased to announce that following the announcement of the Final Results for the year ended 31 December 2024 , Rick Guiney (CEO) and Konrad Dabrowski (CFO) will hold a live presentation on the Company via the Investor Meet Company platform on 9 June 2025 at 5.30p.m. GMT.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9.00a.m. GMT on 6 June 2025 or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet MicroSalt plc via:

https://www.investormeetcompany.com/microsalt-plc/register

Investors who already follow MicroSalt plc on the Investor Meet Company platform will automatically be invited.

For more information, please visit www.microsaltinc.co , follow on X @microSaltPLC or contact:

MicroSalt plc	Via Flagstaff PR
Rick Guiney, CEO
Zeus (Nominated adviser and broker)	+44 (0)20 3829 5000
David Foreman, James Edis (Investment Banking)
Flagstaff PR (Financial PR)	+44 (0)20 7129 1474
Tim Thompson / Alison Allfrey / Anna Probert         microsalt@flagstaffcomms.com

About MicroSalt ®

MicroSalt® produces a patented full-flavour, low-sodium salt for food manufacturers and consumers.

MicroSalt is a major potential disruptor in the food market, thanks to its micron sized particles which deliver the same sense of saltiness to a wide range of foods but with approximately 50% less sodium. Excess sodium consumption is a significant contributor to cardiovascular disease and MicroSalt's solution meets the rising demand for healthier alternatives to traditional salt. The WHO has set a target for reducing global sodium intake by 30% by 2025, which it estimates will save 7 million lives by 2030.

Each year, cardiovascular disease costs the UK £19 billion - if the average salt intake was reduced by one gram per day, it has been estimated that 4,147 lives and £288 million would be saved each year in the UK. As a nation, the UK consumes 183 million kilograms of salt each year, and 70 per cent. of the typical person's sodium intake is hidden in processed foods.

Operational since 2018, MicroSalt uses patent-protected technology which helps create high barriers to entry within the reduced-sodium salt market. The group has a US patent and 14 patent applications pending in other jurisdictions globally.

The Directors believe that MicroSalt is well positioned to capture growth in the low sodium market, which is expected to grow exponentially, and that there is also potential to enter the larger salt market.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUPUPAQUPAGMG